Investigating surgical techniques to reduce stroke risk during heart surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effects of left atrial appendage resection and Marshall ligament amputation on clinical outcomes in patients undergoing off-pump coronary artery bypass surgery. It aims to determine whether these surgical interventions can reduce the incidence of new-onset atrial fibrillation and subsequent stroke risk. The study focuses on patients who are undergoing isolated first off-pump coronary artery bypass, excluding those with a history of atrial fibrillation or other significant health issues. By analyzing postoperative outcomes, the research seeks to provide insights into optimizing surgical techniques for better patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* isolated first off-pump coronary artery bypass

Exclusion Criteria:

* Preoperative atrial fibrillation or a history of atrial fibrillation;
* Concurrent cardiac or non-cardiac surgery
* Intraoperative convert to bypass bypass surgery
* Emergency surgery
* History of previous cardiac surgery
* Severe organ dysfunction

Where it's running

• Fuwai Hospital
  Beijing, China Recruiting

Study contacts

• Principal investigator: Hansong Sun, doctor — Chinese Academy of Medical Sciences, Fuwai Hospital
• Study coordinator: Hengchao Wu, doctor
• Email: whcwuhengchao@163.com
• Phone: 010-88322355

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Optimal antithrombotic strategy for patients with atrial fibrillation undergoing PCI

  This study is testing whether a new blood-thinning treatment for patients with atrial fibrillation undergoing heart procedures is safer and just as effective as the traditional approach that includes more medications.

  Recruiting at 18 sites Phase 4 St. Antonius Hospital · Aalst and 19 other locations · NCT04436978

• AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals

  This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.

  Recruiting at 2 sites Hospital Universitari Vall d'Hebron Research Institute · Leuven and 6 other locations · NCT07924371

• Medical AI fine-tuning platform for major diseases

  This study tests a smart AI system that uses hospital data to help diagnose and guide care for patients with chronic gastritis, gastric cancer, reflux, coronary artery disease, or stroke.

  Recruiting Beijing Friendship Hospital · Beijing · NCT07795645

• Apixaban with or without Clopidogrel in stroke patients with NVAF and intracranial/extracranial atherosclerosis

  This study tests whether adding clopidogrel to apixaban is safe and helpful for people with acute ischemic stroke due to non-valvular atrial fibrillation and atherosclerosis.

  Recruiting Phase 4 Yonsei University · Seoul · NCT07237308

• Managing multiple medications in older adults with chronic diseases

  This project will see if taking many different medicines changes the health outlook of people aged 65 and older who have chronic conditions.

  Recruiting Xijing Hospital · Xi'an, Shaanxi · NCT07180368

• Three-year follow-up after pCAD-POAF

  This study follows people who were in the pCAD-POAF trial to see how they’re doing three years after their surgery.

  Recruiting China National Center for Cardiovascular Diseases · Beijing · NCT07146061

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.